Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135 SUNC Q1 2026 Earnings Significant Earnings Miss Amid Challenging Quarter ABBV Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips PostRelease HBANL Q1 2026 Earnings Preferred Shares Edge Up Despite Significant EPS Miss CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition